Innovation Archive

Medtronic and Tidepool Work Together on Interoperable Automated Insulin Pump System for Diabetes Management

  This afternoon we announced that we will be working with Tidepool to create an interoperable automated insulin pump system. This means that both companies will be working closely with the Food and Drug Administration (FDA) through the regulatory process to garner approvals for the components needed for an interoperable system, including a future

Getting to Know Dr. Robert Vigersky

The Diabetes Group at Medtronic is full of people who are pushing the status quo to help those living with diabetes live healthier lives. Today, we’d like to help you get to know Dr. Robert Vigersky, our Chief Medical Officer. Dr. Vigersky plays a leading role for us in leading our clinical work and

Who Is Driving Innovation at Medtronic?

  At Medtronic, innovation is vital so that we can continue to improve the lives of people living with diabetes. Our Research & Development (R&D) team is at the center of that innovation. However, we realize that it’s important for the team to stay centered on patients’ needs. That’s why we focus on having

Meet IQcast, the Newest Addition to the Sugar.IQ assistant

Over the last few months, it’s been great to hear the positive feedback from those of you using the Guardian Connect Smart CGM with the Sugar.IQ assistant. Today, the system gets even smarter, with IQcast technology, a new addition to the Sugar.IQ assistant experience. The IQcast feature is like a weather forecast for your

How the Guardian Connect Smart CGM can Help with Time in Range

References 1 Nicolucci A, Kovacs Burns K, et al. Research: Educational and Psychological Issues Diabetes Attitudes, Wishes and Needs second study. Diabet Med. 2013;30:767–777. 2 Close KL, Wood R. Outcomes Measures for New Diabetes Therapies Beyond A1c. Presented at: FDA; August 29, 2016; Silver Spring, MD. https://diatribe.org/patient-priorities-diabetes-drugs-what-does-success-look. Accessed April 27, 2018. 3 Kaufman FR,